• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物发现中的多维定量构效关系

Multi-dimensional QSAR in drug discovery.

作者信息

Lill Markus A

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.

出版信息

Drug Discov Today. 2007 Dec;12(23-24):1013-7. doi: 10.1016/j.drudis.2007.08.004. Epub 2007 Sep 19.

DOI:10.1016/j.drudis.2007.08.004
PMID:18061879
Abstract

Quantitative structure-activity relationships (QSAR) is an area of computational research that builds virtual models to predict quantities such as the binding affinity or the toxic potential of existing or hypothetical molecules. Although a wealth of experimental data emphasizes the active role of the target protein in the binding process, QSAR studies are frequently restricted to the properties of the small-molecule ligand. This review aims at discussing recent QSAR concepts exploring higher dimensions (simulation of induced fit, simultaneous exploration of alternative binding modes, and solvation scenarios), and their benefit for the drug-discovery process.

摘要

定量构效关系(QSAR)是计算研究的一个领域,它构建虚拟模型来预测诸如现有或假设分子的结合亲和力或潜在毒性等数量。尽管大量实验数据强调了靶蛋白在结合过程中的积极作用,但QSAR研究通常仅限于小分子配体的性质。本综述旨在讨论探索更高维度的最新QSAR概念(诱导契合模拟、替代结合模式的同时探索和溶剂化情景)及其对药物发现过程的益处。

相似文献

1
Multi-dimensional QSAR in drug discovery.药物发现中的多维定量构效关系
Drug Discov Today. 2007 Dec;12(23-24):1013-7. doi: 10.1016/j.drudis.2007.08.004. Epub 2007 Sep 19.
2
Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters.药物研究中的多维定量构效关系。预测结合亲和力、毒性和药代动力学参数。
Prog Drug Res. 2000;55:105-35.
3
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.抗菌剂的统一定量构效关系方法。4. 抗病毒药物 - 药物复合网络巨型组件的多靶点定量构效关系建模与比较多距离研究。
Bioorg Med Chem. 2009 Jan 15;17(2):569-75. doi: 10.1016/j.bmc.2008.11.075. Epub 2008 Dec 6.
4
In silico prediction of harmful effects triggered by drugs and chemicals.药物和化学物质引发有害效应的计算机模拟预测。
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):398-407. doi: 10.1016/j.taap.2005.01.055.
5
The challenge of predicting drug toxicity in silico.在计算机上预测药物毒性的挑战。
Basic Clin Pharmacol Toxicol. 2006 Sep;99(3):195-208. doi: 10.1111/j.1742-7843.2006.pto_471.x.
6
Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.药物设计中的伪受体模型:连接基于配体和受体的虚拟筛选
Nat Rev Drug Discov. 2008 Aug;7(8):667-77. doi: 10.1038/nrd2615. Epub 2008 Jul 18.
7
A novel in silico approach to drug discovery via computational intelligence.一种通过计算智能进行药物发现的新型计算机模拟方法。
J Chem Inf Model. 2009 Apr;49(4):1105-21. doi: 10.1021/ci9000647.
8
In silico prediction of drug-binding strengths to human serum albumin.人血清白蛋白药物结合强度的计算机模拟预测
Med Res Rev. 2003 May;23(3):275-301. doi: 10.1002/med.10039.
9
Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.原子性质场:用于自动配体叠加、药效团阐释和三维定量构效关系的广义三维药效团潜力
Chem Biol Drug Des. 2008 Jan;71(1):15-27. doi: 10.1111/j.1747-0285.2007.00605.x. Epub 2007 Dec 7.
10
Druggability indices for protein targets derived from NMR-based screening data.基于核磁共振筛选数据得出的蛋白质靶点的成药指数。
J Med Chem. 2005 Apr 7;48(7):2518-25. doi: 10.1021/jm049131r.

引用本文的文献

1
Meta-analysis and review of in silico methods in drug discovery - part 1: technological evolution and trends from big data to chemical space.药物发现中计算机模拟方法的荟萃分析与综述 - 第1部分:从大数据到化学空间的技术演变与趋势
Pharmacogenomics J. 2025 Apr 9;25(3):8. doi: 10.1038/s41397-025-00368-z.
2
AbLEF: antibody language ensemble fusion for thermodynamically empowered property predictions.AbLEF:基于抗体语言集成融合的热力学赋能性质预测。
Bioinformatics. 2024 May 2;40(5). doi: 10.1093/bioinformatics/btae268.
3
Scipion-Chem: An Open Platform for Virtual Drug Screening.
Scipion-Chem:一个用于虚拟药物筛选的开放平台。
J Chem Inf Model. 2023 Dec 25;63(24):7873-7885. doi: 10.1021/acs.jcim.3c01085. Epub 2023 Dec 5.
4
Steroids Bearing Heteroatom as Potential Drugs for Medicine.含杂原子甾体作为潜在的医药用药物
Biomedicines. 2023 Oct 3;11(10):2698. doi: 10.3390/biomedicines11102698.
5
An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches.利用计算机辅助药物设计方法开发小分子激酶抑制剂的最新综述
Int J Mol Sci. 2023 Sep 11;24(18):13953. doi: 10.3390/ijms241813953.
6
Computational analysis, alignment and extension of analogue series from medicinal chemistry.药物化学中类似物系列的计算分析、比对和扩展。
Future Sci OA. 2022 Jun 28;8(7):FSO804. doi: 10.2144/fsoa-2022-0033. eCollection 2022 Aug.
7
QSPR Modeling and Experimental Determination of the Antioxidant Activity of Some Polycyclic Compounds in the Radical-Chain Oxidation Reaction of Organic Substrates.关于某些多环化合物在有机底物的自由基链氧化反应中的抗氧化活性的 QSPR 建模和实验测定。
Molecules. 2022 Oct 2;27(19):6511. doi: 10.3390/molecules27196511.
8
QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia.新型双环(芳基甲基)苯甲酰胺作为治疗精神分裂症的有效甘氨酸转运体1抑制剂的定量构效关系、计算机辅助药物代谢动力学、分子对接和分子动力学研究
Pharmaceuticals (Basel). 2022 May 27;15(6):670. doi: 10.3390/ph15060670.
9
Drug Design by Pharmacophore and Virtual Screening Approach.基于药效团和虚拟筛选方法的药物设计
Pharmaceuticals (Basel). 2022 May 23;15(5):646. doi: 10.3390/ph15050646.
10
QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against .QSAR、对接和分子动力学模拟研究 Sigmacidins 作为抗菌剂对抗.
Int J Mol Sci. 2022 Apr 7;23(8):4085. doi: 10.3390/ijms23084085.